Need for this
Pharmacovigilance teams frequently face the challenge of preparing case narratives that meet diverse regulatory and partner-specific requirements. Each authority — such as EMA, USFDA, MHRA, APVMA, and others — specifies unique narrative formats, content fields, and structural expectations.
Manual narrative writing and formatting consume significant reviewer time, introduce inconsistency, and increase the risk of human error. The complexity multiplies in multi-suspect drug cases, multiple adverse events, or follow-up submissions, where maintaining logical consistency and version control is essential.
As case volumes grow, manual processes restrict scalability, delay reporting timelines, and complicate compliance. Regulatory audits further require full traceability of narrative versions, templates, and approval histories — making manual handling inefficient and audit-prone.
How it Benefits
How We Are Using This in Our Products
- Data Auto-Population– Structured data from the safety database is mapped automatically into the relevant narrative template based on authority or sponsor requirements.
- Template Flexibility – PvEdge supports multiple narrative configurations within a single PV system, ensuring tailored outputs for each regulatory or business need.
Template Type | Purpose | Example Output |
Regulatory Template | For EMA/USFDA reporting | Structured narrative for XML submission |
Sponsor-Specific Template | For partner company reports | Custom narrative per sponsor |
Product-Specific Template | For product families (e.g., vaccines, vet drugs) | Tailored content and rules |
Aggregate Report Template | For PADER/PSUR inclusion | Summarised narratives with consistent format |
-
Review & Approval Workflow – Quality Reviewer / PV Manager verifies compliance and finalises narratives.
System Administrator manages template setup, access controls, and configuration. - Version Control & Traceability – Each narrative and template is version-controlled, with a full audit trail to support regulatory inspections and internal QA reviews.
Result of Implementation of PADER
As a service recipient PADER software can streamline pharmacovigilance process, improve report quality by automated data integration and standardized data templates, enhance drug safety monitoring efforts by regular and timely submission, reduce workload by automating repetitive tasks and provide timely reminders, no chance of missing any timeliness.
Result of Implementation
Automation & Efficiency
Reduces narrative preparation time by up to 70%.
Standardisation
Maintains consistent formats and content across authorities and partners.
Error Reduction
Reduces narrative preparation time by up to 70%.
Flexibility & Scalability
Adapts easily to new reporting requirements without IT dependency.
Audit Readiness
Ensures complete traceability of templates, changes, and approvals.
System Integration
Links directly with E2B XMLs, aggregate reports (PADER/PSUR), and partner submissions.
